| Dr Andrew Wayne Morgan, PHARMD | |
|
500 W Fort St, Boise, ID 83702-4501 | |
| (208) 422-1000 | |
| Not Available |
| Full Name | Dr Andrew Wayne Morgan |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 500 W Fort St, Boise, Idaho |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275733438 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | P6087 (Idaho) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andrew Wayne Morgan, PHARMD 500 W Fort St, Boise, ID 83702-4501 Ph: (208) 422-1000 | Dr Andrew Wayne Morgan, PHARMD 500 W Fort St, Boise, ID 83702-4501 Ph: (208) 422-1000 |
News Archive
Writing in the Huffington Post's "The Big Push" blog, Bill Gates, co-chair of the Bill & Melinda Gates Foundation, examines why the Global Fund to Fight AIDS, Tuberculosis and Malaria is a good investment.
The increase of obesity in the United States doubled the number of inconclusive diagnostic imaging exams over a 15-year period, according to a study featured in the August issue of Radiology.
An overwhelming majority of Americans appear to disagree with Fed Chairman Bernanke's statement that the recession is 'likely over' as 78% say it isn't, according to the latest American Pulse Survey of 6,976 Americans. 76% of Democrats, 84% of Republicans and 75.6% of Independents concur, making this one subject that all parties can agree upon.
Researchers at Indiana University and Methodist Research Institute have published the dramatic effects of a natural formula against breast cancer. The impressive results are found in the most recent publication of Integrative Cancer Therapies. Lead investigator Dr. Daniel Sliva says, The formula we studied inhibits growth of highly metastatic human breast cancer cells, and suppresses metastatic potential of these cells.
OXiGENE, Inc., a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, announced today that it presented updated safety and clinical activity data from the FALCON trial, a randomized, controlled Phase 2 study of ZYBRESTAT(TM) (CA4P) in patients with non-small cell lung cancer (NSCLC).
› Verified 2 days ago
Eleanor I Evans, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5005 W Overland Rd, Boise, ID 83705 Phone: 208-389-1448 Fax: 208-389-1458 | |
Ms. Fatima Walizada, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5005 W Overland Rd, Boise, ID 83705 Phone: 208-389-1448 | |
David Lyn Harrison, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9196 W Emerald St, Suite 110, Boise, ID 83704 Phone: 208-323-1259 Fax: 208-323-5666 | |
Mary Gobeille, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5230 W Franklin Rd, Boise, ID 83705 Phone: 208-429-6433 | |
Megan B Seewald, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3233 N Cole Rd, Boise, ID 83704 Phone: 208-501-7032 Fax: 208-501-7026 | |
Dr. Christopher K Johnson, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3232 Elder Street, Boise, ID 83705 Phone: 208-364-1829 Fax: 180-032-7554 | |
Dr. Catherine M Oliphant, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 300 E Jefferson St, Suite 201, Boise, ID 83712 Phone: 208-381-4146 Fax: 208-381-1665 |